Chapter 1: Executive Summary 1.1. Market scope and segmentation 1.2. Key questions answered in the study 1.3. Executive summary Chapter 2: Introduction 2.1. Market definitions 2.2. Market trends 2.3. Market drivers 2.4. Market challenges 2.5. Revenue based on product type - (USD Bn) (2018) 2.6. Value chain analysis of the global interventional cardiology devices market Chapter 3: Global interventional cardiology devices market overview 3.1. Market overview 3.1.1. Global historical market revenue (USD Bn) (2016-2017) 3.1.2. Global forecast market revenue (USD Bn) (2018-2023) 3.1.3. Geography-wise market revenue (USD Bn) (2018 and 2023) Chapter 4: Global interventional cardiology devices market - based on product type 4.1. Drug-eluting stents market 4.1.1. Revenue - (2015, 2018 and 2023) (USD Bn) 4.1.2. Trends 4.1.3. Drivers 4.2. Catheters market 4.2.1. Revenue - (2015, 2018 and 2023) (USD Bn) 4.2.2. Trends 4.2.3. Drivers 4.3. Bare-metal stents market 4.3.1. Revenue - (2015, 2018 and 2023) (USD Bn) 4.3.2. Trends 4.3.3. Drivers 4.4. Guidewires market 4.4.1. Revenue - (2015, 2018 and 2023) (USD Bn) 4.4.2. Trends 4.4.3. Drivers 4.5. Other interventional cardiology devices market 4.5.1. Revenue - (2015, 2018 and 2023) (USD Bn) 4.5.2. Trends 4.5.3. Drivers Chapter 5: Global interventional cardiology devices market - based on regions 5.1. North America 5.1.1. Overview 5.1.2. Revenue - (2015-2023) (USD Bn) 5.1.3. Key highlights 5.2. Europe 5.2.1. Overview 5.2.2. Revenue - (2015-2023) (USD Bn) 5.2.3. Key highlights 5.3. Asia-Pacific 5.3.1. Overview 5.3.2. Revenue - (2015-2023) (USD Bn) 5.3.3. Key highlights 5.4. Latin America 5.4.1. Overview 5.4.2. Revenue - (2015-2023) (USD Bn) 5.4.3. Key highlights 5.5. The Middle East and Africa 5.5.1. Overview 5.5.2. Revenue - (2015-2023) (USD Bn) 5.5.3. Key highlights Chapter 6: Market share of companies 6.1. Companies’ share in the global interventional cardiology devices market Chapter 7: Competitive landscape 7.1. Abbott Laboratories 7.1.1. Company snapshot 7.1.2. Key financials 7.1.3. Business description and major products 7.1.4. Global presence 7.1.5. Major initiatives 7.1.6. Growth strategies Note: Similar information areas will be covered for the competitors 7.2. Boston Scientific Corporation 7.3. Medtronic 7.4. Terumo Corporation 7.5. Edwards Lifesciences Corporation 7.6. Becton Dickinson 7.7. Johnson & Johnson 7.8. B. Braun Melsungen 7.9. Teleflex Incorporated 7.10. MicroPort Scientific Corporation Chapter 8: Conclusion 8.1. Conclusion Chapter 9: Appendix 9.1. List of tables 9.2. Assumptions 9.3. Research methodology 9.4. About Research On Global Markets 9.5. Disclaimer

Abbott Laboratories Boston Scientific Corporation Medtronic Terumo Corporation Edwards Lifesciences Corporation Becton Dickinson Johnson & Johnson B. Braun Melsungen Teleflex Incorporated MicroPort Scientific Corporation